Literature DB >> 1450501

Noonan syndrome presenting growth hormone neurosecretory dysfunction.

K Tanaka1, A Sato, T Naito, K Kuramochi, H Itabashi, Y Takemura.   

Abstract

Noonan syndrome has been diagnosed by the characteristic physical stigmata for more than two decades. Recent studies of growth hormone secretory pattern provide a new category of growth hormone neurosecretory dysfunction to characterize short stature. We describe herein a case of growth hormone neurosecretory dysfunction in a 16-year-old boy with Noonan syndrome. Growth hormone neurosecretory dysfunction was diagnosed primarily based on the low amplitude and small numbers of the spontaneous bursts of growth hormone secretion during 12-hour nocturnal growth hormone sampling. Treatment with synthetic human growth hormone has markedly accelerated the growth velocity for one year and a half. This case notes the wide spectrum of short stature in Noonan syndrome and the effectiveness of treatment with human growth hormone.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1450501     DOI: 10.2169/internalmedicine.31.908

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  6 in total

1.  Noonan syndrome: clinical aspects and molecular pathogenesis.

Authors:  M Tartaglia; G Zampino; B D Gelb
Journal:  Mol Syndromol       Date:  2010-01-15

2.  Defective growth hormone (GH) secretion and short-term treatment in Noonan syndrome.

Authors:  A T Soliman; A Rajab; M el Zalabany; I alSalmi; M A Fattah
Journal:  Indian J Pediatr       Date:  1998 Sep-Oct       Impact factor: 1.967

3.  GH Responsiveness in Children With Noonan Syndrome Compared to Turner Syndrome.

Authors:  Jovanna Dahlgren; Kerstin Albertsson-Wikland
Journal:  Front Endocrinol (Lausanne)       Date:  2021-11-09       Impact factor: 5.555

4.  Outcomes in growth hormone-treated Noonan syndrome children: impact of PTPN11 mutation status.

Authors:  Alexander A L Jorge; Thomas Edouard; Mohamad Maghnie; Alberto Pietropoli; Nicky Kelepouris; Alicia Romano; Martin Zenker; Reiko Horikawa
Journal:  Endocr Connect       Date:  2022-04-15       Impact factor: 3.221

5.  Five-year response to growth hormone in children with Noonan syndrome and growth hormone deficiency.

Authors:  Niki Zavras; Cristina Meazza; Alba Pilotta; Chiara Gertosio; Sara Pagani; Carmine Tinelli; Mauro Bozzola
Journal:  Ital J Pediatr       Date:  2015-10-06       Impact factor: 2.638

Review 6.  Etiology and Treatment of Growth Delay in Noonan Syndrome.

Authors:  Fernando Rodríguez; Ximena Gaete; Fernando Cassorla
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-04       Impact factor: 5.555

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.